Thailand · Delayed Price · Currency is THB Healthlead PCL Statistics
Total Valuation
Healthlead PCL has a market cap or net worth of THB 1.14 billion. The enterprise value is 1.02 billion.
| Market Cap | 1.14B |
| Enterprise Value | 1.02B |
Important Dates
The next estimated earnings date is Tuesday, November 17, 2026.
| Earnings Date | Nov 17, 2026 |
| Ex-Dividend Date | Mar 11, 2026 |
Share Statistics
Healthlead PCL has 253.88 million shares outstanding. The number of shares has decreased by -3.99% in one year.
| Current Share Class | 253.88M |
| Shares Outstanding | 253.88M |
| Shares Change (YoY) | -3.99% |
| Shares Change (QoQ) | -1.68% |
| Owned by Insiders (%) | 73.91% |
| Owned by Institutions (%) | 0.20% |
| Float | 66.25M |
Valuation Ratios
The trailing PE ratio is 19.72.
| PE Ratio | 19.72 |
| Forward PE | n/a |
| PS Ratio | 0.50 |
| PB Ratio | 1.30 |
| P/TBV Ratio | 1.34 |
| P/FCF Ratio | 11.98 |
| P/OCF Ratio | 9.54 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.47, with an EV/FCF ratio of 10.73.
| EV / Earnings | 17.21 |
| EV / Sales | 0.45 |
| EV / EBITDA | 5.47 |
| EV / EBIT | 11.45 |
| EV / FCF | 10.73 |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.33.
| Current Ratio | 3.34 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 1.56 |
| Debt / FCF | 3.06 |
| Interest Coverage | 5.12 |
Financial Efficiency
Return on equity (ROE) is 6.44% and return on invested capital (ROIC) is 9.52%.
| Return on Equity (ROE) | 6.44% |
| Return on Assets (ROA) | 3.87% |
| Return on Invested Capital (ROIC) | 9.52% |
| Return on Capital Employed (ROCE) | 7.76% |
| Weighted Average Cost of Capital (WACC) | 5.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 3 |
| Asset Turnover | 1.57 |
| Inventory Turnover | 4.97 |
Taxes
In the past 12 months, Healthlead PCL has paid 15.02 million in taxes.
| Income Tax | 15.02M |
| Effective Tax Rate | 20.17% |
Stock Price Statistics
The stock price has decreased by -41.44% in the last 52 weeks. The beta is 0.27, so Healthlead PCL's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -41.44% |
| 50-Day Moving Average | 5.35 |
| 200-Day Moving Average | 6.24 |
| Relative Strength Index (RSI) | 19.01 |
| Average Volume (20 Days) | 315,960 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Healthlead PCL had revenue of THB 2.26 billion and earned 59.45 million in profits. Earnings per share was 0.23.
| Revenue | 2.26B |
| Gross Profit | 584.58M |
| Operating Income | 89.34M |
| Pretax Income | 74.47M |
| Net Income | 59.45M |
| EBITDA | 137.36M |
| EBIT | 89.34M |
| Earnings Per Share (EPS) | 0.23 |
Balance Sheet
The company has 411.11 million in cash and 291.89 million in debt, with a net cash position of 119.22 million or 0.47 per share.
| Cash & Cash Equivalents | 411.11M |
| Total Debt | 291.89M |
| Net Cash | 119.22M |
| Net Cash Per Share | 0.47 |
| Equity (Book Value) | 878.17M |
| Book Value Per Share | 3.46 |
| Working Capital | 570.78M |
Cash Flow
In the last 12 months, operating cash flow was 119.72 million and capital expenditures -24.33 million, giving a free cash flow of 95.39 million.
| Operating Cash Flow | 119.72M |
| Capital Expenditures | -24.33M |
| Depreciation & Amortization | 48.03M |
| Net Borrowing | -58.55M |
| Free Cash Flow | 95.39M |
| FCF Per Share | 0.38 |
Margins
Gross margin is 25.81%, with operating and profit margins of 3.94% and 2.63%.
| Gross Margin | 25.81% |
| Operating Margin | 3.94% |
| Pretax Margin | 3.29% |
| Profit Margin | 2.63% |
| EBITDA Margin | 6.07% |
| EBIT Margin | 3.94% |
| FCF Margin | 4.21% |
Dividends & Yields
This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 4.76%.
| Dividend Per Share | 0.22 |
| Dividend Yield | 4.76% |
| Dividend Growth (YoY) | 29.41% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 95.29% |
| Buyback Yield | 3.99% |
| Shareholder Yield | 8.75% |
| Earnings Yield | 5.20% |
| FCF Yield | 8.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Healthlead PCL has an Altman Z-Score of 4.61 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.61 |
| Piotroski F-Score | 6 |